BG Medicine, Inc. Obtains $40,000,000 Series D Financing

  • Feed Type
  • Date
    7/17/2008
  • Company Name
    BG Medicine, Inc.
  • Mailing Address
    610 Lincoln Street North Waltham, MA 02451
  • Company Description
    BG Medicine is a life sciences company focused on the discovery, development and commercialization of novel molecular diagnostics based on biomarkers to improve patient outcomes and contain healthcare costs. Our technology platform uniquely positions us to rapidly and cost-effectively discover new high-value biomarkers over a broad range of therapeutic categories that promise to be highly correlated to clinical outcomes. We have built a broad product pipeline that focuses on cardiovascular disease, cancer and CNS disorders through academic collaborations and initiatives with major pharmaceutical companies, the U.S Food and Drug Administration, or FDA and other healthcare organizations.
  • Website
    http://www.bg-medicine.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $40,000,000
  • Transaction Round
    Series D
  • Proceeds Purposes
    The funding will enable BG Medicine to complete development and commercialization of the company’s first two diagnostic products and continue discovery and development of additional product candidates.
  • M&A Terms
  • Venture Investor
    Legg Mason Inc.
  • Venture Investor
    Flagship Ventures
  • Venture Investor
    Humana Inc.

By posting a comment, you agree to our terms and conditions.